Table 2.

The mean value (pre- and 10 days post-rTMS sessions) of the different rating scales among the studied groups.

	Baseline Assessment	Follow-Up 10 Days after Sessions [% of Improvement]	Wilcoxon Measure Analysis	Effect Size	Friedman Measure Analysis Time × Group Interaction
Parkinson’s Disease Sleep Scale (PDSS)
Sham group (n = 8) Median (IQR)	14.14 ± 2.19 14(4)	13.14 ± 3.80 14(4), [1(12.5%)] #	Z = −1.000, p = 0.317	[0.756] a	p = 0.001 *
Real group (n = 16) Median (IQR)	14.12 ± 2.55 14(3)	7.62 ± 3.89 6.5(3.75), [13(81.25%)] #	Z = −3.524, p = 0.001 *	[3.724] a
Mann–Whitney at each time of assessment	Z = −0.031, p = 0.975	Z = −2.818, p = 0.0005 *
MDS-UPDRS (motor sections II and III)
Sham group (n = 8) Median (IQR)	60.37 ± 33.41 58.5(70)	56.75 ± 37.64 57(72), [1(12.5%)] #	Z = −1.604, p = 0.109	[1.377] a	p = 0.001 *
Real group (n = 16) Median (IQR)	66.31 ± 23.41 63.5(42.75)	45.25 ± 20.86 38.5(27.25), [9(56.25%)] #	Z = −3.521, p = 0.001 *	[3.71] a
Mann–Whitney at each time of assessment	Z = −0.523, p = 0.601	Z = −0.769, p = 0.442
Beck Depression Inventory Scale (BDI)
Sham group (n = 8) Median (IQR)	15.42 ± 6.57 16(9)	15.28 ± 6.67 16(9), [0(0%)] #	Z = −1.000, p = 0.317	[0.756] a	p = 0.001 *
Real group (n = 16) Median (IQR)	14.87 ± 6.35 15.5(10.5)	8.87 ± 5.85 9(9.75), [12(75%)] #	Z = −3.412, p = 0.001 *	[3.269] a
Mann–Whitney at each time of assessment	Z = −0.034, p = 0.973	Z = −1.848, p = 0.065

^a Cohen’s d coefficient, IQR; interquartile range, # the percentage of patients who developed improvement >= 30%, * significant p value.